Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial investigating lysergic acid diethylamide (LSD) for the treatment of cluster headaches, which is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lysergic acid diethylamide (LSD) (Lysergic acid diethylamide)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Cluster Headache | Phase 2 | Status: RECRUITING